JORDAN BRIGNAC: Open Payments
NPI 1528410594 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 38 payments from 10 companies in 2025. Trend: 2023 $890 · 2024 $757 · 2025 $754
Food & beverage: $654Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $221 |
| Astellas Pharma US Inc | 7 | $216 |
| GlaxoSmithKline, LLC. | 9 | $170 |
| MERZ NORTH AMERICA, INC. | 1 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Veozah, TRELEGY ELLIPTA, UBRELVY, VRAYLAR, QULIPTA, Xeomin, AREXVY, FANAPT.
Industry payments across LA — which companies pay providers there.
